Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11597-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11597-1-AP, RRID:AB_2121789
- Product name
- IFI30 antibody
- Antibody type
- Polyclonal
- Description
- IFI30 antibody (Cat. #11597-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TIGIT impairs NK cell antifibrotic activity through the IFNγ-IFI30 axis in schistosomiasis-induced liver fibrosis.
Unveiling Gamma-Interferon-Inducible Lysosomal Thiol Reductase (IFI30) as a Regulator of Macrophage Polarization and Prognostic Biomarker by Multi-Transcriptome Analysis in Cervical Cancer.
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates.
Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell Proliferation.
IFI30 Knockdown Inhibits ESCC Progression by Promoting Apoptosis and Senescence via Activation of JNK and P21/P16 Pathways.
Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease.
Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress.
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Peng H, Zhang J, Zhang X, Zhou H, Cui L, Xu F, Jiang T, Yin J, Hu Y, Shen Y, Lu S, Cao J
Frontiers in immunology 2026;17:1766930
Frontiers in immunology 2026;17:1766930
Unveiling Gamma-Interferon-Inducible Lysosomal Thiol Reductase (IFI30) as a Regulator of Macrophage Polarization and Prognostic Biomarker by Multi-Transcriptome Analysis in Cervical Cancer.
Wang W, Deng Y, Feng Y, Chen R, Xu M, Chen P, Yuan S
IUBMB life 2025 Sep;77(9):e70056
IUBMB life 2025 Sep;77(9):e70056
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates.
Xu W, Wu T, Liu Y, Luo Y, Liu D, Yan L, Li Q, Wang T
Recent patents on anti-cancer drug discovery 2025 Feb 6;
Recent patents on anti-cancer drug discovery 2025 Feb 6;
Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell Proliferation.
Liu Q, Yuan X, Shao Y, Guan X, Feng K, Chu M, Chen L, Li H, Liu H, Zhang J, Tian Y, Wei L
Cancer innovation 2025 Apr;4(2):e161
Cancer innovation 2025 Apr;4(2):e161
IFI30 Knockdown Inhibits ESCC Progression by Promoting Apoptosis and Senescence via Activation of JNK and P21/P16 Pathways.
Xie W, Wei S, Feng C, Fu Y, Zhang Z, Dai S, Zhang C, Zhao L, Shan B
Thoracic cancer 2025 Apr;16(7):e70063
Thoracic cancer 2025 Apr;16(7):e70063
Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
Chen X, Zhang Z, Qin Z, Zhu X, Wang K, Kang L, Li C, Wang H
Aging 2024 Mar 20;16(6):5676-5702
Aging 2024 Mar 20;16(6):5676-5702
CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease.
Yanda MK, Ciobanu C, Guggino WB, Cebotaru L
American journal of physiology. Cell physiology 2023 Sep 1;325(3):C682-C693
American journal of physiology. Cell physiology 2023 Sep 1;325(3):C682-C693
Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress.
Chen M, Zhang R, Chen Y, Chen X, Li Y, Shen J, Yuan M, Chen Y, Wu J, Sun Q
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 Jul 25;116:154902
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 Jul 25;116:154902
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Fan Y, Wang X, Li Y
International journal of medical sciences 2021;18(14):3342-3352
International journal of medical sciences 2021;18(14):3342-3352
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The IFI30 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human IFI30. This antibody recognizes human antigen. The IFI30 antibody has been validated for the following applications: ELISA, WB analysis.
